Related Experiment Video
Updated: Jun 26, 2026
08:55
Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
Published on: April 15, 2016
Oncolytic virotherapy for advanced liver tumours
Ju-Fang Chang1, Pei-Jer Chen, Daniel Y Sze
1Department of Pathology and Immunology, Washington University in Saint Louis, Saint Louis, MO, USA.
Journal of Cellular and Molecular Medicine
|January 30, 2009
Summary
Oncolytic virotherapeutics offer a promising new approach for treating liver cancer by selectively destroying cancer cells and stimulating the immune system. This review explores their potential and future directions for hepatic neoplasms.
Area of Science:
- Oncology
- Virology
- Gene Therapy
Background:
- Primary and metastatic liver neoplasms cause over a million deaths annually worldwide.
- Existing therapies for liver cancer are limited, necessitating novel treatment strategies.
- Oncolytic virotherapeutics present a promising new class of drugs for hepatic neoplasms.
Purpose of the Study:
- To review the current applications of oncolytic virotherapeutics in treating hepatic neoplasms.
- To summarize pre-clinical and clinical advancements in virotherapy for liver cancer.
- To discuss the challenges and future prospects of oncolytic virotherapy for liver cancers.
Main Methods:
- Review of existing pre-clinical and clinical studies on oncolytic virotherapeutics for liver cancer.
- Analysis of the mechanisms of action, including cancer-specific replication, oncolysis, and transgene expression.
- Evaluation of therapeutic potential against apoptosis-resistant tumor cells and multiple carcinogenic pathways.
Main Results:
- Oncolytic virotherapeutics demonstrate cancer-specific replication leading to oncolysis and spread to adjacent cancer cells.
- These agents target multiple oncogenic pathways and exhibit activity against apoptosis-resistant tumor cells.
- The platform allows for combined direct viral oncolysis and therapeutic transgene expression.
Conclusions:
- Oncolytic virotherapeutics show significant potential as a novel therapeutic strategy for primary and metastatic liver cancers.
- Further research and clinical studies are essential to overcome challenges and optimize virotherapy for hepatic neoplasms.
- This therapeutic class offers a unique approach by combining direct tumor destruction with enhanced anti-cancer mechanisms.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...